266 related articles for article (PubMed ID: 24368295)
1. Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.
Sheinerman KS; Tsivinsky VG; Abdullah L; Crawford F; Umansky SR
Aging (Albany NY); 2013 Dec; 5(12):925-38. PubMed ID: 24368295
[TBL] [Abstract][Full Text] [Related]
2. Plasma microRNA biomarkers for detection of mild cognitive impairment.
Sheinerman KS; Tsivinsky VG; Crawford F; Mullan MJ; Abdullah L; Umansky SR
Aging (Albany NY); 2012 Sep; 4(9):590-605. PubMed ID: 23001356
[TBL] [Abstract][Full Text] [Related]
3. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
4. Molecular Changes in Circulating microRNAs' Expression and Oxidative Stress in Adults with Mild Cognitive Impairment: A Biochemical and Molecular Study.
Al-Rawaf HA; Alghadir AH; Gabr SA
Clin Interv Aging; 2021; 16():57-70. PubMed ID: 33447019
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment.
Xie B; Zhou H; Zhang R; Song M; Yu L; Wang L; Liu Z; Zhang Q; Cui D; Wang X; Xu S
J Alzheimers Dis; 2015; 45(3):721-31. PubMed ID: 25589731
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
8. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus.
Salama II; Sami SM; Abdellatif GA; Mohsen A; Rasmy H; Kamel SA; Ibrahim MH; Mostafa M; Fouad WA; Raslan HM
PLoS One; 2020; 15(7):e0236453. PubMed ID: 32726329
[TBL] [Abstract][Full Text] [Related]
10. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
14. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
15. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
Sabry R; El Sharkawy RE; Gad NM
Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
[TBL] [Abstract][Full Text] [Related]
16. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.
Hsu YF; Lin SP; Chu YT; Tsai YT; Huang JW; Phoa FKH; Wu RM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542526
[TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
18. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
19. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
20. Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population.
Zhang X; Wang Y; Liu W; Wang T; Wang L; Hao L; Ju M; Xiao R
Am J Clin Nutr; 2021 Aug; 114(2):429-440. PubMed ID: 33871591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
